18 January 2018 - - The Woodbury, New York-based pancreatic research funding organization Lustgarten Foundation funded USD 22m in 2017 as part of its commitment to invest USD 40m by the end of 2018, the Foundation said.
In addition to funding ...
18 January 2018 - - Washington, DC-based immuno-oncology biotechnology company GT Biopharma Inc. (OTCQB: GTBP) (Euronext Paris: GTBP.PA) has appointed Geoffrey B. Davis to its board of directors, effective immediately, the company said.
Davis ...
18 January 2018 - - St. John's, Newfoundland and Labrador-based biotechnology company Sequence Bio has named Dr. Michael S. Phillips as chief scientific officer, the company said.
Phillips will lead all scientific development projects and...
18 January 2018 - - Vancouver, British Columbia-based prostate cancer treatment developer ESSA Pharma Inc. (TSXV: EPI; NASDAQ: EPIX) has closed the second tranche of its brokered equity offering, raising an additional USD 4m from a fund managed by Om...
18 January 2018 - - The US Food and Drug Administration has accepted the biologics license application from Holzkirchen, Germany-based biosimilar medicines specialist Sandoz, a Novartis division, submitted under the 351 (k) pathway, for proposed bios...